Premium
Expression of Fas ligand in human hepatoma cell lines: Role of hepatitis‐B virus X (HBX) in induction of Fas ligand
Author(s) -
Shin EuiCheol,
Shin JeonSoo,
Park JeonHan,
Kim Hoguen,
Kim SeJong
Publication year - 1999
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19990812)82:4<587::aid-ijc19>3.0.co;2-9
Subject(s) - hbx , fas ligand , transfection , biology , frameshift mutation , hepatitis b virus , microbiology and biotechnology , apoptosis , virology , cell culture , immune system , cancer research , virus , programmed cell death , immunology , mutation , gene , genetics
It has been postulated that tumor cells expressing Fas ligand (FasL) can evade immune surveillance by inducing apoptosis in T cells expressing Fas. In this study, we investigated FasL expression in 13 human hepatoma cell lines. Strong FasL expression was detected by reverse transcription‐polymerase chain reaction or immunofluorescence in Hep G2.2.15, in which the hepatitis‐B‐virus (HBV) genome was transfected, and in SNU‐354, which showed HBx transcripts. To determine the biological activity of FasL, Hep G2.2.15 was co‐cultured with MOLT‐4, T‐cell‐leukemia cells. Hep G2.2.15 induced apoptosis in MOLT‐4 and this was inhibited by the antagonistic anti‐Fas antibody, ZB4. For further analysis of the role of HBx in the induction of FasL, PLC/PRF/5 cells were transfected transiently with the HBV genome, or HBx , or the frameshift mutant of HBx . In PLC/PRF/5 cells transfected with the HBV genome or HBx but not in cells transfected with the frameshift mutant of HBx , FasL expression was detected. Our data suggest that HBx plays a role in the induction of FasL in hepatoma cells and in the escape from immune surveillance. Int. J. Cancer 82:587–591, 1999. © 1999 Wiley‐Liss, Inc.